Esophageal cancer, the eighth most prevalent malignancy globally and the sixth leading cause of cancer mortality, is often diagnosed at an advanced stage due to nonspecific early symptoms. As a result, curative treatment options are frequently unfeasible, leading to a reliance on palliative care to alleviate debilitating symptoms like dysphagia, pain, and malnutrition, ultimately enhancing patient quality of life. Palliative care strategies, tailored for both squamous cell carcinoma and adenocarcinoma, involve a multidisciplinary approach, integrating radiation therapy, endoscopic stenting, and nutritional support. Radiation, including intraluminal brachytherapy and external beam therapy, offers dysphagia relief but requires careful patient selection to minimize risks, such as fistula formation. Endoscopic stents, especially self-expanding metal stents (SEMS), provide immediate symptom relief, although complications such as stent migration and tumor ingrowth necessitate vigilant management. Additionally, management of sialorrhea, nausea, and pain is paramount, utilizing pharmacologic and interventional options to enhance patient comfort. For patients with respiratory symptoms due to tumor invasion, airway stents or double stenting for fistula closure may be employed. As esophageal cancer progresses, timely advance care planning and comprehensive end-of-life care are crucial for addressing physical, psychological, and existential needs, underscoring patient autonomy and dignity.

Palliative Treatment for Esophageal Cancer

de Manzoni, Giovanni;
2026-01-01

Abstract

Esophageal cancer, the eighth most prevalent malignancy globally and the sixth leading cause of cancer mortality, is often diagnosed at an advanced stage due to nonspecific early symptoms. As a result, curative treatment options are frequently unfeasible, leading to a reliance on palliative care to alleviate debilitating symptoms like dysphagia, pain, and malnutrition, ultimately enhancing patient quality of life. Palliative care strategies, tailored for both squamous cell carcinoma and adenocarcinoma, involve a multidisciplinary approach, integrating radiation therapy, endoscopic stenting, and nutritional support. Radiation, including intraluminal brachytherapy and external beam therapy, offers dysphagia relief but requires careful patient selection to minimize risks, such as fistula formation. Endoscopic stents, especially self-expanding metal stents (SEMS), provide immediate symptom relief, although complications such as stent migration and tumor ingrowth necessitate vigilant management. Additionally, management of sialorrhea, nausea, and pain is paramount, utilizing pharmacologic and interventional options to enhance patient comfort. For patients with respiratory symptoms due to tumor invasion, airway stents or double stenting for fistula closure may be employed. As esophageal cancer progresses, timely advance care planning and comprehensive end-of-life care are crucial for addressing physical, psychological, and existential needs, underscoring patient autonomy and dignity.
2026
9789819612963
N.A.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1208887
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact